-
MD Anderson, Rush bring new partnership to Chicago
Rush MD Anderson Cancer Center is coming to Chicago. The new partnership marks University of Texas MD Anderson's seventh hospital partnership across the U.S., and is expected to expand access to clinical trials and advanced care to patients in Chicago and surrounding communities. -
Hoag taps 2 oncology leaders from Cedars-Sinai
Newport Beach, Calif.-based Hoag Family Cancer Institute recruited an oncologist "power couple" — Monica Mita, MD, and Alain Mita, MD — to serve as leaders in its organization. -
OU Health cancer center expands across state
Oklahoma City-based OU Health Stephenson Cancer Center is expanding to the northeastern part of the state. -
Oncologist burnout up 18%: 6 things to know
Sixty-four percent of oncologists said they have felt burned out for at least 13 months — an 18% increase over last year's responses, according to a Medscape report. -
MercyOne ends gynecologic oncology surgery services
MercyOne's specialty clinic in Des Moines is ending gynecologic oncology surgical services June 1, ABC affiliate KCCI reported April 23. -
FDA approves new bladder cancer drug
The FDA has approved a first-in-class bladder cancer drug. -
5% more cancer drugs prescribed after these visits — but outcomes did not change
Physicians prescribe 5% more cancer drugs following a pharmaceutical representitive's visit, but the practice does not appear to affect cancer patients' mortality, NPR reported April 22. -
UPMC study identifies new tool in fight against rare eye tumor
University of Pittsburgh Medical Center researchers found a way to predict when a rare eye cancer will respond to treatment, The Washington Post reported April 22. -
Jefferson cancer center earns NCI designation
The National Cancer Institute recognized Philadelphia-based Jefferson Health's Sidney Kimmel Cancer Center as a comprehensive cancer center. -
2 business moves pulling physicians from care, per 1 oncology leader
The implementation of IT solutions that pull physicians away from patients and moving profits to payer groups are two issues that concern John Montville, executive director of the oncology service line at Mercy Health-Lourdes Hospital in Paducah, Ky. -
Cedars-Sinai Cancer appoints melanoma research director
Bin Zheng, PhD, who specializes in targeted therapies and immunotherapy, was appointed director of melanoma research in the Department of Biomedical Sciences at Los Angeles-based Cedars-Sinai Cancer. -
Cancer rates in younger adults: 4 trends to know
A growing body of research shows cancer rates are on the rise in adults younger than 50. In response, many oncologists have pointed to the need for more awareness across the healthcare continuum, stronger care coordination on the primary care side to ensure early detection and treatment, and continued research investments to pinpoint what's behind rising rates. -
MD Anderson partners on mRNA cancer vaccines
Houston-based University of Texas MD Anderson Cancer Center has partnered with CureVac, a global biopharmaceutical company, to develop novel mRNA-based cancer vaccines. -
Breast cancer surgery reimbursements fell 24% in 20 years: Study
Medicare reimbursement for common breast cancer surgeries have declined significantly over the last 20 years, a new study from researchers at the Fox Chase Cancer Center and Temple University Hospital, both based in Philadelphia, found. -
18% of oncologists consider leaving medicine due to burnout
Eighteen percent of oncologists said their burnout is so severe that they may leave medicine, according to a Medscape report. -
This common gas could be linked to rise in lung cancer
Columbus-based Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital found that the "concerning rise" in nonsmoking lung cancer cases could be due to radon gas. -
Maine systems to close cancer practice
St. Mary's Health System will close its oncology practice, St. Mary's Center For Cancer and Blood Disorders, on July 1, ABC affiliate WMTW reported April 12. -
Cancer patient trial participation doubles projections: Study
Cancer patients participating in treatment trials is twice as high than historical estimates, a recent study found. -
Cleveland Clinic, AtlantiCare partner on cancer care
Cleveland Clinic Cancer Institute is partnering with Egg Harbor Township, N.J.-based AtlantiCare Cancer Institute to expand access to advanced research, clinical trials and cancer treatment for AtlantiCare patients. -
Funding for Cancer Moonshot nixed, but more left for grants: NCI director
The funding bill for the National Cancer Institute and the National Institutes of Health have been finalized, leaving the NCI with $96 million less than its fiscal year 2023 total enacted budget but $120 million more compared to the base budget.
Page 15 of 50